Irene Moreno-Candilejo (Irene Moreno)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Binding Protein

Radical Prostatectomy

Top Venues

International journal of molecular sciences

Science translational medicine

Pharmaceuticals (Basel, Switzerland)

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Lucía Paniagua-Herranz, Irene Moreno-Candilejo, Cristina Nieto-Jiménez, Esther Garcia-Lorenzo, Cristina Díaz-Tejeiro, Adrián Sanvicente, Bernard Doger, Manuel Pedregal, Jorge Ramón, Jorge Bartolomé, Arancha Manzano, Balázs Gyorffy, Alvaro Gutiérrez-Uzquiza, Pedro Pérez Segura, Emiliano Calvo, Víctor Moreno, Alberto Ocaña
Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2. International journal of molecular sciences 25 (4) (2024)
Lucía Paniagua-Herranz, Irene Moreno-Candilejo, Cristina Nieto-Jiménez, Esther Garcia-Lorenzo, Cristina Díaz-Tejeiro, Adrián Sanvicente, Bernard Doger, Manuel Pedregal, Jorge Ramón, Jorge Bartolomé, Arancha Manzano, Balázs Gyorffy, Alvaro Gutiérrez-Uzquiza, Pedro Pérez Segura, Emiliano Calvo, Víctor Moreno, Alberto Ocaña
Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2. International journal of molecular sciences 25 (4) (2024)
Lucía Paniagua-Herranz, Irene Moreno-Candilejo, Cristina Nieto-Jiménez, Esther Garcia-Lorenzo, Cristina Díaz-Tejeiro, Adrián Sanvicente, Bernard Doger, Manuel Pedregal, Jorge Ramón, Jorge Bartolomé, Arancha Manzano, Balázs Gyorffy, Alvaro Gutiérrez-Uzquiza, Pedro Pérez Segura, Emiliano Calvo, Víctor Moreno, Alberto Ocaña
Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2. International journal of molecular sciences 25 (4) (2024)
Lucía Paniagua-Herranz, Irene Moreno-Candilejo, Cristina Nieto-Jiménez, Esther Garcia-Lorenzo, Cristina Díaz-Tejeiro, Adrián Sanvicente, Bernard Doger, Manuel Pedregal, Jorge Ramón, Jorge Bartolomé, Arancha Manzano, Balázs Gyorffy, Alvaro Gutiérrez-Uzquiza, Pedro Pérez Segura, Emiliano Calvo, Víctor Moreno, Alberto Ocaña
Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2. International journal of molecular sciences 25 (4) (2024)
Irene Moreno-Candilejo, Tatiana Hernández, Emiliano Calvo, Salvador Fudio, Carmen Kahatt, Cristian Fernández, Jorge Luis Iglesias, Gema Corral, Laura Pérez-Ramos, Lola Montilla, Ali Zeaiter, Rubin Lubomirov
Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug-Drug Interaction Study. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Irene Moreno-Candilejo, Tatiana Hernández, Emiliano Calvo, Salvador Fudio, Carmen Kahatt, Cristian Fernández, Jorge Luis Iglesias, Gema Corral, Laura Pérez-Ramos, Lola Montilla, Ali Zeaiter, Rubin Lubomirov
Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug-Drug Interaction Study. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Ignacio Melero Bermejo, Tamara Tanos, Mariana Bustamante, Miguel F Sanmamed, Emiliano Calvo, Irene Moreno-Candilejo, Victor Moreno, Tatiana Hernández, Maria Martinez-García, Alejo Rodriguez-Vida, Josep Tabernero, Analia Azaro, Mariano Ponz-Sarvisé, Iben Spanggaard, Kristoffer Staal Rohrberg, Ernesto Guarin, Eveline Nüesch, Iakov I Davydov, Chia-Huey Ooi, José Duarte, Evelyne Chesne, Christine McIntyre, Maurizio Ceppi, Marta Cañamero, Oliver Krieter
A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors. Science translational medicine 15 (695) (2023)
Alexandra Drakaki, Thomas Powles, Aristotelis Bamias, Juan Martín-Liberal, Sang Joon Shin, Terence W Friedlander, Diego Tosi, Chandler Park, Carlos Alberto Gomez Roca, Florence Joly Lobbedez, Daniel Castellano, Rafael Morales-Barrera, Irene Moreno-Candilejo, Aude Flechon, Kobe Yuen, Deepali Rishipathak, Kelly DuPree, Fiona Young, Francesca Michielin, Colby S Shemesh, Elizabeth E Steinberg, Patrick Williams, Jae Lyun Lee
Atezolizumab Plus Magrolimab, Niraparib, or Tocilizumab in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Randomized Umbrella Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ignacio Melero Bermejo, Tamara Tanos, Mariana Bustamante, Miguel F Sanmamed, Emiliano Calvo, Irene Moreno-Candilejo, Victor Moreno, Tatiana Hernández, Maria Martinez-García, Alejo Rodriguez-Vida, Josep Tabernero, Analia Azaro, Mariano Ponz-Sarvisé, Iben Spanggaard, Kristoffer Staal Rohrberg, Ernesto Guarin, Eveline Nüesch, Iakov I Davydov, Chia-Huey Ooi, José Duarte, Evelyne Chesne, Christine McIntyre, Maurizio Ceppi, Marta Cañamero, Oliver Krieter
A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors. Science translational medicine 15 (695) (2023)